Imcivii

setmelanotide · Rhythm Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Imcivii, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway [Phase 3]